| Stock | PriceCurrent trading price. | Market CapTotal market capitalization. | FKPrice to Earnings ratio. | PD/DDPrice to Book ratio. | EV/EBITDAEnterprise Value / EBITDA. | ROICReturn on Invested Capital. | WACCWeighted Average Cost of Capital (WACC). | PUSLAFinancial health score (0-100). | DamodaranValuation score. | Intrinsic ValueFair value via DCF model. | Potential %Expected upside potential %. | Dalio RiskDalio Debt Cycle Score | Debt/EquityDebt to Equity ratio. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
GSRAY
|
1.01 | 13.6B | 12.14 | 0.86 | 3.05 | -9.1% | 36.5% | 52 | 32 | 2.04 | +51.5% | 44 | 0.17 |
|
FENER
|
3.07 | 10.3B | — | — | 3.25 | -77.6% | 39.6% | 49 | 23 | 6.40 | +46.6% | 41 | -9.55 |
|
BJKAS
|
1.97 | 8.6B | — | 2.47 | 6.15 | -50.3% | 26.8% | 32 | 17 | 1.54 | -11.2% | 40 | 1.56 |
|
TSPOR
|
1.02 | 3.4B | — | 5.67 | 108.59 | -86.7% | 39.8% | 21 | 10 | 0.26 | -38.2% | 16 | 2.23 |
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.